The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pharmaceutical Asset Management-Global Market Insights and Sales Trends 2025
Synopsis
The global Pharmaceutical Asset Management market size is expected to reach US$ 149.7 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Asset Management in various end use industries. The expanding demands from the Anti-drug Counterfeiting and Supply Chain Management, are propelling Pharmaceutical Asset Management market. Hardware(Pharma Asset), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Software(Pharma Asset) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Asset Management, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Asset Management market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Asset Management market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Asset Management sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Asset Management covered in this report include McKesson Corporation, Cerner Corporation, Siemens Healthcare, GE Healthcare, Allscripts, Epic System and IBM Corporation, etc.
The global Pharmaceutical Asset Management market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
McKesson Corporation
Cerner Corporation
Siemens Healthcare
GE Healthcare
Allscripts
Epic System
IBM Corporation
Global Pharmaceutical Asset Management market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Asset Management market, Segment by Type:
Hardware(Pharma Asset)
Software(Pharma Asset)
Global Pharmaceutical Asset Management market, by Application
Anti-drug Counterfeiting
Supply Chain Management
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Asset Management companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Pharmaceutical Asset Management market size is expected to reach US$ 149.7 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Asset Management in various end use industries. The expanding demands from the Anti-drug Counterfeiting and Supply Chain Management, are propelling Pharmaceutical Asset Management market. Hardware(Pharma Asset), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Software(Pharma Asset) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Asset Management, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Asset Management market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Asset Management market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Asset Management sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Asset Management covered in this report include McKesson Corporation, Cerner Corporation, Siemens Healthcare, GE Healthcare, Allscripts, Epic System and IBM Corporation, etc.
The global Pharmaceutical Asset Management market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
McKesson Corporation
Cerner Corporation
Siemens Healthcare
GE Healthcare
Allscripts
Epic System
IBM Corporation
Global Pharmaceutical Asset Management market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Asset Management market, Segment by Type:
Hardware(Pharma Asset)
Software(Pharma Asset)
Global Pharmaceutical Asset Management market, by Application
Anti-drug Counterfeiting
Supply Chain Management
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Asset Management companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pharmaceutical Asset Management
1.1 Pharmaceutical Asset Management Market Overview
1.1.1 Pharmaceutical Asset Management Product Scope
1.1.2 Pharmaceutical Asset Management Market Status and Outlook
1.2 Global Pharmaceutical Asset Management Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Asset Management Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Asset Management Historic Market Size by Region (2018-2023)
1.5 Global Pharmaceutical Asset Management Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Asset Management Market Size (2018-2029)
1.6.1 North America Pharmaceutical Asset Management Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Asset Management Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Asset Management Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Asset Management Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Asset Management Market Size (2018-2029)
2 Pharmaceutical Asset Management Market by Type
2.1 Introduction
2.1.1 Hardware(Pharma Asset)
2.1.2 Software(Pharma Asset)
2.2 Global Pharmaceutical Asset Management Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Asset Management Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmaceutical Asset Management Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Asset Management Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Asset Management Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Asset Management Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Asset Management Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Asset Management Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Asset Management Market Overview by Application
3.1 Introduction
3.1.1 Anti-drug Counterfeiting
3.1.2 Supply Chain Management
3.2 Global Pharmaceutical Asset Management Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Asset Management Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmaceutical Asset Management Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Asset Management Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Asset Management Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Asset Management Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Asset Management Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Asset Management Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Asset Management Competition Analysis by Players
4.1 Global Pharmaceutical Asset Management Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Asset Management as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Asset Management Market
4.4 Global Top Players Pharmaceutical Asset Management Headquarters and Area Served
4.5 Key Players Pharmaceutical Asset Management Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Asset Management Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 McKesson Corporation
5.1.1 McKesson Corporation Profile
5.1.2 McKesson Corporation Main Business
5.1.3 McKesson Corporation Pharmaceutical Asset Management Products, Services and Solutions
5.1.4 McKesson Corporation Pharmaceutical Asset Management Revenue (US$ Million) & (2018-2023)
5.1.5 McKesson Corporation Recent Developments
5.2 Cerner Corporation
5.2.1 Cerner Corporation Profile
5.2.2 Cerner Corporation Main Business
5.2.3 Cerner Corporation Pharmaceutical Asset Management Products, Services and Solutions
5.2.4 Cerner Corporation Pharmaceutical Asset Management Revenue (US$ Million) & (2018-2023)
5.2.5 Cerner Corporation Recent Developments
5.3 Siemens Healthcare
5.3.1 Siemens Healthcare Profile
5.3.2 Siemens Healthcare Main Business
5.3.3 Siemens Healthcare Pharmaceutical Asset Management Products, Services and Solutions
5.3.4 Siemens Healthcare Pharmaceutical Asset Management Revenue (US$ Million) & (2018-2023)
5.3.5 GE Healthcare Recent Developments
5.4 GE Healthcare
5.4.1 GE Healthcare Profile
5.4.2 GE Healthcare Main Business
5.4.3 GE Healthcare Pharmaceutical Asset Management Products, Services and Solutions
5.4.4 GE Healthcare Pharmaceutical Asset Management Revenue (US$ Million) & (2018-2023)
5.4.5 GE Healthcare Recent Developments
5.5 Allscripts
5.5.1 Allscripts Profile
5.5.2 Allscripts Main Business
5.5.3 Allscripts Pharmaceutical Asset Management Products, Services and Solutions
5.5.4 Allscripts Pharmaceutical Asset Management Revenue (US$ Million) & (2018-2023)
5.5.5 Allscripts Recent Developments
5.6 Epic System
5.6.1 Epic System Profile
5.6.2 Epic System Main Business
5.6.3 Epic System Pharmaceutical Asset Management Products, Services and Solutions
5.6.4 Epic System Pharmaceutical Asset Management Revenue (US$ Million) & (2018-2023)
5.6.5 Epic System Recent Developments
5.7 IBM Corporation
5.7.1 IBM Corporation Profile
5.7.2 IBM Corporation Main Business
5.7.3 IBM Corporation Pharmaceutical Asset Management Products, Services and Solutions
5.7.4 IBM Corporation Pharmaceutical Asset Management Revenue (US$ Million) & (2018-2023)
5.7.5 IBM Corporation Recent Developments
6 North America
6.1 North America Pharmaceutical Asset Management Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Asset Management Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Asset Management Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Asset Management Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Asset Management Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Asset Management Market Dynamics
11.1 Pharmaceutical Asset Management Industry Trends
11.2 Pharmaceutical Asset Management Market Drivers
11.3 Pharmaceutical Asset Management Market Challenges
11.4 Pharmaceutical Asset Management Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
